Pharmovital ApS: Financial statements 2016
CVR: 27206506
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
Pharmovital ApS (CVR 27206506) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,850,436 and a net result of DKK 310,325 compared with DKK 481,325 the year before. That is an increase of 2.3% compared with the year before. Equity in the 2016 report amounted to DKK 1,127,830. The solvency ratio was 38%.
- Gross Profit
- DKK 1,850,436
- Profit/Loss
- DKK 310,325
- Equity
- DKK 1,127,830
- Total Assets
- DKK 2,966,461
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1.9 mio. | 310 t. | 1.1 mio. | - |
| 2015 | - | 1.8 mio. | 481 t. | 818 t. | - |
| 2014 | - | 1.7 mio. | -942 t. | 336 t. | 2 |
| 2013 | - | 1.5 mio. | 481 t. | 1.3 mio. | - |
Official annual report
Find more companies like Pharmovital ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Pharmovital ApS
Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 6 employees (2026). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.